GRADE Guidelines Reinforce Intranasal Corticosteroids as First-Line Therapy for Chronic Rhinosinusitis with Nasal Polyps
核心洞察
Chronic rhinosinusitis with nasal polyposis (搜索) affects 2-4% of the global population, causing significant quality of life impairment through nasal congestion and smell loss.
Intranasal corticosteroids (搜索) remain the cornerstone of first-line medical therapy, demonstrating effectiveness in reducing polyp size and improving nasal airflow.
Recent evidence supports combining high-volume irrigation with intranasal corticosteroids (搜索) for enhanced drug delivery, though long-term use concerns persist.
The management of chronic rhinosinusitis with nasal polyposis (搜索) (CRSwNP (搜索)) has received renewed attention with the recent publication of GRADE guidelines, reinforcing the fundamental role of intranasal corticosteroids (搜索) (INCS (搜索)) in treatment protocols. This inflammatory condition, affecting approximately 2-4% of the global population, presents significant challenges in patient care and quality of life management.
Disease Burden and Clinical Presentation
CRSwNP (搜索) manifests through persistent sinonasal inflammation and polyp formation, leading to debilitating symptoms including nasal congestion and anosmia. The condition significantly impacts patients' daily activities and requires a comprehensive treatment approach combining both pharmacological and surgical interventions.
Therapeutic Role of Intranasal Corticosteroids
The GRADE guidelines have strongly endorsed INCS (搜索) as the primary medical therapy for CRSwNP (搜索) management. These medications have demonstrated consistent efficacy in:
- Reducing polyp size
- Improving nasal airflow
- Alleviating associated symptoms
Advanced Delivery Methods and Treatment Optimization
Recent clinical evidence has highlighted the advantages of combining high-volume irrigation with INCS (搜索) administration. This approach enhances drug delivery to the sinonasal cavities, potentially improving treatment outcomes. However, healthcare providers must carefully consider several factors:
- Patient adherence to prescribed regimens
- Potential systemic absorption risks
- Long-term safety considerations
Treatment Considerations and Monitoring
While INCS (搜索) therapy is generally well-tolerated, ongoing monitoring remains essential. Healthcare providers must balance efficacy optimization with risk management, particularly for patients requiring extended treatment periods. Regular assessment of treatment response and potential adverse effects helps ensure optimal therapeutic outcomes.
Future Therapeutic Directions
The evolving understanding of CRSwNP (搜索) pathophysiology continues to inform treatment approaches. While INCS (搜索) remains the cornerstone of therapy, research into improved delivery methods and combination treatments may further enhance patient outcomes in the future.